VCSA Fundamental Analysis - VACASA INC -CL A

Name: VACASA INC -CL A (VCSA) Stock
Brand: VACASA INC -CL A
Rating: 4 (3 reviews)

Fundamental Rating

VCSA gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 133 industry peers in the Hotels, Restaurants & Leisure industry. VCSA has a bad profitability rating. Also its financial health evaluation is rather negative. VCSA is valied quite expensively at the moment, while it does show a decent growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year VCSA has reported negative net income.

In the past year VCSA has reported a negative cash flow from operations.

VCSA had negative earnings in each of the past 5 years.

VCSA had negative operating cash flow in 4 of the past 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of -33.75%, VCSA is doing worse than 96.32% of the companies in the same industry.

VCSA has a Return On Equity of -530.94%. This is in the lower half of the industry: VCSA underperforms 66.18% of its industry peers.

		Industry Rank	Sector Rank
ROA	-33.75%
ROE	-530.94%
ROIC	N/A

ROA(3y)-25.47%

ROA(5y)-15.44%

ROE(3y)-183.48%

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

Looking at the Gross Margin, with a value of 52.44%, VCSA is in the better half of the industry, outperforming 63.24% of the companies in the same industry.

VCSA's Gross Margin has improved in the last couple of years.

VCSA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	52.44%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y1.43%

GM growth 5Y3.43%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

VCSA does not have a ROIC to compare to the WACC, probably because it is not profitable.

VCSA has more shares outstanding than it did 1 year ago.

VCSA has more shares outstanding than it did 5 years ago.

Compared to 1 year ago, VCSA has a worse debt to assets ratio.

2.2 Solvency

VCSA has an Altman-Z score of -1.98. This is a bad value and indicates that VCSA is not financially healthy and even has some risk of bankruptcy.

VCSA has a worse Altman-Z score (-1.98) than 94.12% of its industry peers.

A Debt/Equity ratio of 3.59 is on the high side and indicates that VCSA has dependencies on debt financing.

VCSA has a Debt to Equity ratio (3.59) which is comparable to the rest of the industry.

		Industry Rank	Sector Rank
Debt/Equity	3.59
Debt/FCF	N/A
Altman-Z	-1.98

ROIC/WACCN/A

WACC9.46%

2.3 Liquidity

A Current Ratio of 0.77 indicates that VCSA may have some problems paying its short term obligations.

With a Current ratio value of 0.77, VCSA perfoms like the industry average, outperforming 41.91% of the companies in the same industry.

VCSA has a Quick Ratio of 0.77. This is a bad value and indicates that VCSA is not financially healthy enough and could expect problems in meeting its short term obligations.

The Quick ratio of VCSA (0.77) is comparable to the rest of the industry.

		Industry Rank	Sector Rank
Current Ratio	0.77
Quick Ratio	0.77

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

VCSA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -159.73%.

Looking at the last year, VCSA shows a small growth in Revenue. The Revenue has grown by 0.17% in the last year.

Measured over the past years, VCSA shows a very strong growth in Revenue. The Revenue has been growing by 24.92% on average per year.

EPS 1Y (TTM)-159.73%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%20.69%

Revenue 1Y (TTM)0.17%

Revenue growth 3Y0.8%

Revenue growth 5Y24.92%

Sales Q2Q%-22.23%

3.2 Future

Based on estimates for the next years, VCSA will show a very strong growth in Earnings Per Share. The EPS will grow by 27.20% on average per year.

The Revenue is expected to grow by 9.15% on average over the next years. This is quite good.

EPS Next Y70.11%

EPS Next 2Y27.2%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next Year-9.63%

Revenue Next 2Y-4.95%

Revenue Next 3Y12.44%

Revenue Next 5Y9.15%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

VCSA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for VCSA. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as VCSA's earnings are expected to grow with 27.20% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y27.2%

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

VCSA does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

VACASA INC -CL A

NASDAQ:VCSA (4/30/2025, 8:00:01 PM)

After market: 5.38 -0.01 (-0.19%)

5.39

+0.02 (+0.37%)

Chartmill FA Rating

GICS SectorConsumer Discretionary

GICS IndustryGroupConsumer Services

GICS IndustryHotels, Restaurants & Leisure

Earnings (Last)05-07 2025-05-07/amc

Earnings (Next)08-06 2025-08-06/amc

Inst Owners36.72%

Inst Owner Change0%

Ins Owners10.07%

Ins Owner Change-48.29%

Market Cap123.27M

Revenue(TTM)1.12B

Net Income(TTM)-180876000

Analysts50

Price Target2.55 (-52.69%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)1

Avg EPS beat(2)-2.5%

Min EPS beat(2)-11.64%

Max EPS beat(2)6.63%

EPS beat(4)2

Avg EPS beat(4)-18.5%

Min EPS beat(4)-138.75%

Max EPS beat(4)69.74%

EPS beat(8)6

Avg EPS beat(8)225.06%

EPS beat(12)8

Avg EPS beat(12)170.99%

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)1

Avg Revenue beat(2)-2.79%

Min Revenue beat(2)-6.48%

Max Revenue beat(2)0.9%

Revenue beat(4)2

Avg Revenue beat(4)-1.44%

Min Revenue beat(4)-6.48%

Max Revenue beat(4)2.24%

Revenue beat(8)6

Avg Revenue beat(8)1.25%

Revenue beat(12)9

Avg Revenue beat(12)1.67%

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)0%

EPS NQ rev (1m)0%

EPS NQ rev (3m)0%

EPS NY rev (1m)3.67%

EPS NY rev (3m)3.67%

Revenue NQ rev (1m)0%

Revenue NQ rev (3m)0%

Revenue NY rev (1m)0%

Revenue NY rev (3m)-0.53%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	0.11
P/FCF	N/A
P/OCF	N/A
P/B	3.62
P/tB	N/A
EV/EBITDA	N/A

EPS(TTM)-7.61

EYN/A

EPS(NY)-2.27

Fwd EYN/A

FCF(TTM)-5.17

FCFYN/A

OCF(TTM)-4.81

OCFYN/A

SpS48.97

BVpS1.49

TBVpS-6.69

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-33.75%
ROE	-530.94%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	52.44%
FCFM	N/A

ROA(3y)-25.47%

ROA(5y)-15.44%

ROE(3y)-183.48%

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y1.43%

GM growth 5Y3.43%

F-Score4

Asset Turnover2.09

Health

		Industry Rank	Sector Rank
Debt/Equity	3.59
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	27.27%
Cap/Sales	0.73%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	0.77
Quick Ratio	0.77
Altman-Z	-1.98

F-Score4

WACC9.46%

ROIC/WACCN/A

Cap/Depr(3y)21.95%

Cap/Depr(5y)22.37%

Cap/Sales(3y)1.2%

Cap/Sales(5y)1.36%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-159.73%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%20.69%

EPS Next Y70.11%

EPS Next 2Y27.2%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)0.17%

Revenue growth 3Y0.8%

Revenue growth 5Y24.92%

Sales Q2Q%-22.23%

Revenue Next Year-9.63%

Revenue Next 2Y-4.95%

Revenue Next 3Y12.44%

Revenue Next 5Y9.15%

EBIT growth 1Y-40.99%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year102.73%

EBIT Next 3Y35.32%

EBIT Next 5Y23.28%

FCF growth 1Y-83.5%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-112.78%

OCF growth 3YN/A

OCF growth 5YN/A

VACASA INC -CL A / VCSA FAQ

Can you provide the ChartMill fundamental rating for VACASA INC -CL A?

ChartMill assigns a fundamental rating of 2 / 10 to VCSA.

Can you provide the valuation status for VACASA INC -CL A?

ChartMill assigns a valuation rating of 1 / 10 to VACASA INC -CL A (VCSA). This can be considered as Overvalued.

Can you provide the profitability details for VACASA INC -CL A?

VACASA INC -CL A (VCSA) has a profitability rating of 1 / 10.

How financially healthy is VACASA INC -CL A?

The financial health rating of VACASA INC -CL A (VCSA) is 1 / 10.

VACASA INC -CL A (VCSA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

VACASA INC -CL A / VCSA FAQ

Can you provide the ChartMill fundamental rating for VACASA INC -CL A?

Can you provide the valuation status for VACASA INC -CL A?

Can you provide the profitability details for VACASA INC -CL A?

How financially healthy is VACASA INC -CL A?